XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

Manman Deng, Mingzhi Zhang, Zijun Y. Xu-Monette, Lan V. Pham, Alexandar Tzankov, Carlo Visco, Xiaosheng Fang, Govind Bhagat, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, William W.L. Choi, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Michael B. Møller, Benjamin M. ParsonsJ. Han van Krieken, Miguel A. Piris, Jane N. Winter, Fredrick Hagemeister, Lapo Alinari, Yong Li, Michael Andreeff, Bing Xu*, Ken H. Young

*Kontaktforfatter

Publikation: Bidrag til tidsskriftLetterForskningpeer review

4 Citationer (Scopus)
4 Downloads (Pure)
OriginalsprogEngelsk
Artikelnummer148
TidsskriftJournal of Hematology & Oncology
Vol/bind13
Udgave nummer1
DOI
StatusUdgivet - 1 dec. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53'. Sammen danner de et unikt fingeraftryk.

Citationsformater